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The value of delta neutrophil index 
in young infants with febrile urinary 
tract infection
Jung Won Lee1,*, Seong Heon Kim2,*, Se Jin Park3,*, Keum Hwa Lee4,5,*, Jae Hyon Park6,*, 
Andreas Kronbichler7, Michael Eisenhut8, Ji Hong Kim4, Jong Wook Lee9,10 & Jae Il Shin4,5,11
Delta neutrophil index (DNI) is the fraction of circulating immature granulocytes, which reflects severe 
bacterial infections and septic condition but has not been studied in urinary tract infection (UTI). Here, 
we evaluated the value of DNI in predicting acute pyelonephritis (APN) or vesicoureteral reflux (VUR) 
using the data of 288 patients. Conventional inflammatory markers (white blood cell [WBC] count, 
erythrocyte sedimentation rate [ESR], C-reactive protein [CRP]), and DNI were measured. WBC, CRP, 
ESR and DNI were higher in APN than in lower UTI (p < 0.01). Multiple logistic-regression analyses 
showed that DNI was a predictive factor for areas of lack of uptake on dimercaptosuccinic acid (DMSA) 
scans (P < 0.01). The area under the receiver operating characteristic (AUC) was also high for DNI (0.622, 
95% CI 0.558–0.687, P < 0.01) as well as for CRP (0.731, 95% CI 0.673–0.789, P < 0.01) for the prediction 
of DMSA defects. DNI demonstrated the highest area under the ROC curve for diagnosis of VUR (0.620, 
95% CI 0.542–0.698, P < 0.01). To the best of our knowledge, this is a first study demonstrating that 
DNI can be used as a diagnostic marker to distinguish APN from lower UTI and function as a diagnostic 
marker indicative of VUR compared to other conventional markers.
Urinary tract infection (UTI) is one of many bacterial infections common in infants and young children1. Early 
detection of UTI at this age can be difficult due to the fact that the presenting symptoms of UTI such as diarrhea, 
vomiting, decreased oral intake, and irritability are often vague and non-specific during time of onset1,2.
More importantly, clinical and laboratory parameters for the early detection of acute pyelonephritis (APN) 
are required in practice to identify children who could benefit from a Dimercaptosuccinic acid (DMSA) scan. 
In response, several studies have previously reported various potential non-invasive biomarkers that may be 
used to identify a systemic inflammatory response including white blood cell (WBC) counts, C-reactive pro-
tein (CRP), erythrocyte sedimentation rate (ESR), procalcitonin, cytokines, chemokines, cell surface antigens, 
and even immunoglobulins and antibodies against NK cells3. These biomarkers require analytical methods that 
need manual supervision or an experienced technician such as enzyme-linked immunoabsorbent assay and flow 
cytometry. In addition, their clinical usefulness as a diagnostic marker still remains controversial.
During bacterial infection, immature neutrophils such as metamyelocytes, myelocytes and promyelocytes 
enter the peripheral blood stream from the bone marrow as a result of an enhanced production of granulocytes, 
a phenomenon known as “shift to the left”4. Recently, it has become possible for automated hematologic cell ana-
lyzers to provide information on the leukocyte differentials by utilizing the nuclear lobularity of WBC and cyto-
chemical myeloperoxidase (MPO) reaction, and thus, one of our authors has developed the delta neutrophil index 
(DNI) in the ADVIA2120 (Siemens Healthcare Diagnostics) system which is calculated as the difference between 
these two parameters5,6. Recently, several studies have reported that DNI is a more useful marker for predicting 
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mortality than WBC or CRP levels in patients with bacterial sepsis7,8. However, very few validation studies are 
published and there has yet to be a report on the clinical usefulness of DNI in children with UTIs.
Therefore, we aimed at an evaluation of the usefulness of DNI as an inflammatory marker in infants and young 
children with febrile UTI with respect to its potential in identification of APN and vesicoureteral reflux.
Results
Clinical, laboratory and imaging findings of patients are presented in Table 1. CRP and DNI were significantly 
higher in patients showing abnormal ultrasonography (USG). Also, the incidence of DMSA abnormalities, VUR 
and severe VUR was more frequent in the patients with abnormal USG. There were no significant statistical dif-
ferences in age and sex between patients with DMSA abnormalities (APN group) and those without (lower UTI 
group). Conventional inflammatory markers such as WBC counts, ESR, CRP levels were significantly higher in 
the APN group than in the lower UTI group. There was also a significant difference between the APN and lower 
UTI group in terms of DNI. The incidence of VUR and abnormal ultrasonographic findings were more frequent 
in the APN group than in the lower UTI group.
In patients with VUR, WBC counts, ESR, DNI were significantly higher than those of VUR negative patients, 
while CRP levels did not differ between the two groups (Table 2). In addition, ESR and DNI were significantly 
higher in the severe VUR group than in the mild VUR group. In the imaging study, abnormal USG and abnormal 
DMSA findings were higher in the patients with severe VUR than in mild VUR. There were no significant differ-
ences in WBC, hemoglobin (Hb), platelet counts and CRP levels between the two groups.
Multiple logistic regression analyses were also performed to test whether each parameter could be an inde-
pendent predictor for renal USG and DMSA scan abnormalities or the presence of VUR and severe VUR. We 
found that only DNI was an independent predictive factor for renal USG abnormalities in UTI patients, while 
Abnormal USG 
(n = 198) Normal USG (n = 90) P value
DMSA 
abnormalities 
(n = 155)
Normal DMSA 
(n = 133) P value
Age (months) 4.6 ± 3.5 4.9 ± 3.9 0.47 4.3 ± 2.5 4.1 ± 2.1 0.53
Gender (Male/Female) 149/49 60/30 0.15 112/43 97/36 0.90
Laboratory findings
WBC (/mm3) 16,201.3 ± 6,312.2 14,931.3 ± 5,593.1 0.09 17,338 ± 6,290 14,045 ± 5,363 <0.01
Hb (g/L) 11.0 ± 1.0 11.0 ± 1.0 0.90 10.9 ± 1.0 11.1 ± 1.0 0.15
Platelet (x103/μL) 456.3 ± 152.4 454.7 ± 137.2 0.93 463.0 ± 159.4 455.0 ± 132.5 0.64
ESR (mm/h) 40.0 ± 29.2 37.3 ± 29.1 0.45 43.9 ± 31.4 32.6 ± 24.4 <0.01
CRP (mg/L) 58.8 ± 63.6 41.7 ± 37.8 <0.01 71.8 ± 68.1 21.6 ± 27.0 <0.01
DNI (%) 1.3 ± 2.7 0.5 ± 0.9 <0.01 1.5 ± 2.9 0.5 ± 1.1 <0.01
Imaging findings
USG abnormalities — — — 117 (59.1%) 38 (42.2%) <0.01
DMSA abnormalities 117/198 (59.1%) 38/90 (42.2%) 0.01 — — —
VUR 64/198 (32.3%) 14/90 (15.6%) <0.01 65/155 (41.9%) 13/133 (9.8%) <0.01
Severe VUR 49/64 (76.6%) 5/14 (35.7%) <0.01 49/65 (75.4%) 5/13 (38.5%) 0.01
Table 1.  Comparison of variables between patients with and without abnormalities in USG and DMSA 
scans. USG: ultrasonography, DMSA: dimercaptosuccinic acid, WBC: white blood cell, Hb: Hemoglobin, ESR: 
erythrocyte sedimentation rate, CRP: C-reactive protein, DNI: delta neutrophil index, VUR: vesicoureteral reflux.
VUR (n = 78) No VUR (n = 210) P value Severe VUR (n = 54) Mild VUR (n = 24) P value
Age (months) 4.3 ± 2.5 4.1 ± 2.3 0.69 3.9 ± 2.4 5.1 ± 2.3 0.03
Gender (Male/Female) 59/19 150/60 0.55 43/11 16/8 0.25
Laboratory findings
WBC (/mm3) 17,352.8 ± 7,209.4 15,247.4 ± 5,539.2 0.02 16,419.4 ± 6,508.0 19,452.9 ± 8,352.1 0.12
Hb (g/L) 11.1 ± 1.1 10.9 ± 0.9 0.10 11.1 ± 1.1 11.3 ± 1.1 0.53
Platelet (x103/μL) 452.7 ± 154.4 461.7 ± 145.1 0.65 437.3 ± 152.1 487.4 ± 156.6 0.18
ESR (mm/h) 32.5 ± 28.4 41.0 ± 28.8 0.02 21.8 ± 27.3 43.1 ± 28.6 0.02
CRP (mg/L) 64.5 ± 80.6 49.1 ± 28.8 0.11 57.1 ± 56.1 81.2 ± 118.6 0.22
DNI (%) 1.9 ± 3.3 0.7 ± 1.6 <0.01 2.4 ± 3.8 0.9 ± 1.3 <0.01
Imaging findings
USG abnormalities 64/78 (82.1%) 134/210 (63.8%) <0.01 49/54 (90.7%) 15/24 (62.5%) <0.01
DMSA abnormalities 65/78 (83.3%) 90/210 (42.9%) <0.01 49/54 (90.7%) 16/24 (66.7%) 0.01
Table 2.  Comparison of variables between patients with and without VUR and severe VUR. VUR: 
vesicoureteral reflux, WBC: white blood cell, Hb: Hemoglobin, ESR: erythrocyte sedimentation rate, CRP: 
C-reactive protein, DNI: delta neutrophil index, USG: ultrasonography, DMSA: dimercaptosuccinic acid.
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WBC, ESR and CRP were not (Table 3). In addition, DNI and CRP were independent predictive factors for 
DMSA scan abnormalities, while WBC and ESR were not. More importantly, only DNI was an independent pre-
dictive factor for the presence of severe VUR, while WBC, ESR and CRP were not.
The diagnostic properties of the various inflammatory markers were examined for their predictive power 
regarding renal USG and DMSA scan abnormalities, and the presence of both severe and non-severe VUR using 
receiver operating characteristic (ROC) curves (Table 4). Regarding the predictive power for renal ultrasonog-
raphy abnormalities, the median area under the ROC curve (AUC) was 0.549 for WBC (P = 0.18), 0.533 for ESR 
(p = 0.37), 0.579 for CRP (P = 0.03) and 0.573 for DNI (P = 0.05). These results show that the diagnostic property 
represented by AUC of all various inflammatory markers was not high for the prediction of renal USG abnor-
malities. Regarding the predictive power for DMSA scan abnormalities, the median AUC was 0.663 for WBC 
(P < 0.01), 0.622 for DNI (P < 0.01), 0.600 for ESR (P < 0.01) and 0.731 for CRP (P < 0.01). The diagnostic prop-
erty of DNI was not higher than CRP for the prediction of DMSA scan abnormalities. However, the median AUC 
of DNI was highest among all other inflammatory markers for prediction of the presence of VUR (AUC 0.620, 
95% CI 0.542–0.698, P < 0.01) or severe VUR (AUC 0.642, 95% CI 0.549–0.734, P = 0.001) (Figs 1, 2, 3 and 4).
The sensitivity, specificity, positive predictive values (PPV), negative predictive values (NPV), positive like-
lihood ratios (PLR), and negative likelihood ratios (NLR) of the DNI were determined under different cut-off 
values. DNI showed a moderate specificity and low sensitivity for the prediction of renal USG and DMSA scan 
abnormalities and the presence of VUR or severe VUR (Table 5 and Supplementary Figure S1). In addition, 
serum DNI did not correlate with WBC and CRP (Table 6).
Discussion
This study is the first to show that DNI, which reflects the number of circulating granulocyte precursors in the 
blood, can be an effective marker to differentiate APN from lower UTI in young children. Although UTI can be 
localized to the bladder (lower UTI), infection can also spread to the renal parenchyma and cause APN which 
is associated with the formation of a renal scar and increased risk of hypertension and chronic kidney disease 
(CKD)9,10. DMSA scan is considered to be the current gold standard of detecting and evaluating the extent of 
acute renal lesions, but it exposes to radiation and sedation is necessary11,12. Therefore, the selection of children 
who need DMSA scan has been a constant issue of debate13.
Recently, however, the National Institute for Health and Care Excellence (NICE) clinical guideline on urinary 
tract infections discouraged routine imaging of all children with first febrile UTI. According to the most updated 
guidelines, DMSA is recommended only in children less than 3 years of age with atypical or recurrent UTI14. 
Furthermore, American Academy of Pediatrics guidelines also discourage prescribing routine imaging studies for 
first UTI in children aged between 2 and 24 months15. Thus, DMSA is no longer a routine investigation for first febrile 
UTI, as evidence continues to support the fact that the yield of actionable findings from imaging is relatively low.
Until now, the commonly used laboratory inflammatory markers are WBC counts, ESR, CRP, and procalci-
tonin16–19. But, neither clinical parameters nor these inflammatory markers are able to reliably differentiate APN 
USG abnormalities DMSA abnormalities VUR Severe VUR
OR (95% CI)/B P value OR (95% CI)/B P value OR (95% CI)/B P value OR (95% CI)/B P value
WBC 1.000  (1.000–1.000)/0.000 0.98
1.000  
(1.000–1.000)/0.000 0.25
1.000  
(1.000–1.000)/0.000 0.02
1.000  
(1.000–1.000)/0.000 0.16
ESR 0.998  (0.987–1.009)/−0.002 0.72
0.994  
(0.981–1.006)/−0.006 0.29
0.977  
(0.965–0.990)/−0.023 <0.01
0.988  
(0.967–1.008)/−0.012 0.23
CRP 1.005  (0.999–1.011)/0.005 0.09
1.024  
(1.015–1.032)/0.023 0.00
1.007  
(1.000–1.014)/0.007 0.05
0.999  
(0.993–1.006)/−0.001 0.82
DNI 1.297  (1.055–1.595)/0.260 0.01
1.337  
(1.106–1.616)/0.290 <0.01
1.215  
(1.065–1.386)/0.195 <0.01
1.430  
(1.045–1.956)/0.357 0.02
Table 3.  Multiple logistic regression analysis of laboratory parameters for the prediction of USG and 
DMSA abnormalities and VUR or severe VUR. USG: ultrasonography, DMSA: dimercaptosuccinic acid, 
VUR: vesicoureteral reflux, OR: odds ratio, CI: confidence interval, B: regression coefficients, WBC: white blood 
cell, ESR: erythrocyte sedimentation rate, CRP: C-reactive protein, DNI: delta neutrophil index.
USG abnormalities DMSA abnormalities VUR Severe VUR
AUC (95% CI) P value AUC (95% CI) P value AUC (95% CI) P value AUC (95% CI) P value
WBC 0.549 (0.478–0.621) 0.18 0.663 (0.600–0.726) <0.01 0.574 (0.498–0.651) 0.04 0.535 (0.450–0.620) 0.43
ESR 0.533 (0.462–0.605) 0.37 0.600 (0.535–0.666) <0.01 0.406 (0.330–0.482) 0.04 0.350 (0.264–0.435) <0.01
CRP 0.579 (0.507–0.652) 0.03 0.731 (0.673–0.789) <0.01 0.542 (0.465–0.618) 0.27 0.525 (0.440–0.610) 0.57
DNI 0.573 (0.504–0.642) 0.05 0.622 (0.558–0.687) <0.01 0.620 (0.542–0.698) <0.01 0.642 (0.549–0.734) <0.01
Table 4.  AUC values from receiver operating characteristic (ROC) curve of DNI and other inflammatory 
markers for the prediction of USG and DMSA abnormalities and VUR or severe VUR. AUC: Area under the 
curve, DNI: delta neutrophil index, USG: ultrasonography, DMSA: dimercaptosuccinic acid, VUR: vesicoureteral 
reflux, CI: confidence interval, WBC: white blood cell, ESR: erythrocyte sedimentation rate, CRP: C-reactive protein.
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from lower UTI in infants and young children due to the lack of specificity20. Interestingly, in previous studies, 
the proportion of immature granulocytes better correlated with bacterial infection compared to the total WBC 
counts21. Consistent with this finding, the level of immature granulocytes was also suggested as a predictor of 
neonatal sepsis22.
Such stronger association of immature granulocytes percentage with infection is presumed to have been 
demonstrated in these studies because immature granulocytes are massively recruited from bone marrow and 
enter into circulation as part of the innate immune response. In fact, during the early hyperdynamic phase of 
infection, a proinflammatory state is heavily mediated by neutrophils, macrophages and monocytes with release 
of inflammatory cytokines, such as tumor necrosis factor-α (TNF-α) and interleukin-1 and -6. During this phase, 
the systemic inflammatory response suppresses neutrophil apoptosis and thus augments neutrophil-mediated 
killing as part of the innate response while simultaneously increasing lymphocyte apoptosis in the thymus and 
spleen4,23.
Figure 1. Receiver operating characteristic (ROC) curve of DNI and other inflammatory markers for the 
prediction of USG abnormalities. DNI: delta neutrophil index, USG: ultrasonography, WBC: white blood cell, 
ESR: erythrocyte sedimentation rate, CRP: C-reactive protein.
Figure 2. Receiver operating characteristic (ROC) curve of DNI and other inflammatory markers for the 
prediction of DMSA abnormalities. DNI: delta neutrophil index, DMSA: dimercaptosuccinic acid, WBC: 
white blood cell, ESR: erythrocyte sedimentation rate, CRP: C-reactive protein.
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In light of this phenomenon, one of our authors developed a novel value known as the delta neutrophil index 
(DNI) which is calculated by subtracting the leukocyte subfraction counted in the nuclear lobularity channel 
from the leukocyte subfraction obtained through the MPO cytochemical reaction. This value correlates with 
the fraction of immature granulocytes in the peripheral blood under manual counting and by using automated 
hematologic cell analyzer during a routine complete blood count (CBC) test. The value can be calculated easily. 
More importantly, this automated process allows for a faster turnaround time, which has been reported to be a 
crucial factor in improving the quality of patient care and patient outcome, time until diagnosis, and in develop-
ing appropriate treatment plans while also significantly reducing laboratory cost24,25. Furthermore, this advan-
tage becomes more prominent during real-time ordering of laboratory tests of patients with a severe medical 
condition needing early intervention such as sepsis. With regard to the diagnostic validity of this value, results 
from a previous study have shown that, compared to WBC counts or CRP, the DNI value is in fact a more useful 
early marker for disease severity in critically ill patients with sepsis26. Furthermore, several other studies have 
Figure 3. Receiver operating characteristic (ROC) curve of DNI and other inflammatory markers for the 
prediction of VUR. DNI: delta neutrophil index, VUR: vesicoureteral reflux, WBC: white blood cell, ESR: 
erythrocyte sedimentation rate, CRP: C-reactive protein.
Figure 4. Receiver operating characteristic (ROC) curve of DNI and other inflammatory markers for the 
prediction of severe VUR. DNI: delta neutrophil index, VUR: vesicoureteral reflux, WBC: white blood cell, 
ESR: erythrocyte sedimentation rate, CRP: C-reactive protein.
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also revealed that the DNI can help identify infections such as bacteremia and early sepsis in immunocompetent 
children27, patients with adult onset Still’s disease (AOSD)28, patients whose blood culture samples are contami-
nated29, and febrile systemic lupus erythematosus patients30. While many studies have proven that the DNI can be 
potentially useful in the early diagnosis of systemic infection such as sepsis, whether this phenomenon also holds 
true for localized infection such as APN.
Interestingly, our univariate analysis indicated statistically significant differences in the mean DNI and CRP 
values between patients with USG and DMSA abnormalities and those without abnormalities. The same univar-
iate analysis revealed significant difference in the WBC count and ESR but this difference was only significant in 
the comparison between patients with DMSA abnormalities and those with normal DMSA, thus indicating that 
the DNI value better discriminates patients with abnormal USG compared to WBC count and ESR similar to 
CRP.
Similarly, univariate analysis of patients with VUR revealed that the DNI and ESR are able to discriminate 
patients with VUR from those without while at the same time being able to discriminate severe VUR from mild 
VUR. This result shows that an increase in DNI not only can be used to identify patients with VUR and may pre-
dict the severity of the disease based on the level of increase. Considering that ESR is able to differentiate patients 
with VUR while CRP can discriminate patients with either abnormal USG or DMSA findings in the absence of 
DNI, neither of these inflammatory markers is able to give complete information in formulating a clinical impres-
sion of a patient. Moreover, both markers would need to be measured to supplement each other’s lack of clinical 
information. However, with the DNI, both information regarding the probability of abnormal USG and DMSA 
scan results along with the probability of presence and severity of VUR may be obtained with one test.
Consistent with these findings, our multiple logistic regression analysis indicates that DNI value is the only 
marker that is statistically significant in predicting USG and DMSA abnormalities and both presence of VUR 
and severe VUR. All other markers were found to be significant in predicting one of four groups: the WBC count 
and ESR for the presence of VUR, and CRP for the presence of DMSA abnormalities. In the multiple logistic 
regression analysis, the only marker that was statistically significant for USG abnormalities and severe VUR was 
the DNI.
In addition, while the AUC of DNI in patients with USG abnormalities was borderline significant (P = 0.05) 
it was nearly comparable to that of CRP, both of which being much more significant than either the WBC count 
and ESR. Admittedly, an AUC value less than 0.6 is not indicative of an acceptable accuracy and thus the AUC 
of DNI in patients with USG abnormalities may signal poor accuracy as a diagnostic tool. However, compared 
Variable Criterion Sensitivity Specificity
Positive 
predictive value
Negative 
predictive value Positive LR Negative LR
USG 
abnormalities >0.4 38.38 (31.6–45.5) 71.11 (60.6–80.2) 12.9 (6.6–21.8) 91.2 (86.4–94.7) 1.33 (0.9–1.9) 0.87 (0.7–1.0)
>0.9 31.31 (24.9–38.3) 82.22 (72.7–89.5) 16.4 (7.8–28.8) 91.5 (87.2–94.8) 1.76 (1.1–2.9) 1.33 (0.9–1.9)
>1.3* 26.77 (20.7–33.5) 87.78 (79.2–93.7) 19.6 (8.7–35.3) 91.5 (87.3–94.7) 2.19 (1.2–4.0) 0.83 (0.7–0.9)
DMSA 
abnormalities >0.4 45.16 (37.2–53.3) 75.94 (67.8–82.9) 17.3 (9.5–27.7) 92.6 (88.2–95.7) 1.88 (1.3–2.7) 0.72 (0.6–0.9)
>0.9 37.42 (29.8–45.5) 84.96 (77.7–90.6) 21.7 (11.2–35.6) 92.4 (88.3–95.5) 2.49 (1.6–3.9) 0.74 (0.6–0.8)
>1.3* 33.55 (26.2–41.6) 90.98 (84.8–95.3) 29.2 (14.8–47.6) 92.5 (88.5–95.4) 3.72 (2.1–6.7) 0.73 (0.6–0.8)
VUR >0.4 48.72 (37.2–53.3) 75.94 (67.8–82.9) 15.1 (8.5–24.0) 92.4 (87.8–95.7) 1.60 (1.2–2.2) 0.74 (0.6–0.9)
>0.9 42.31 (31.2–54.0) 78.57 (72.4–83.9) 18.0 (9.7–29.2) 92.5 (88.1–95.6) 1.97 (1.4–2.8) 0.73 (0.6–0.9)
>1.3 39.74 (28.8–51.5) 84.29 (78.6–88.9) 21.9 (11.7–35.6) 92.6 (88.5–95.6) 2.53 (1.7–3.8) 0.71 (0.6–0.9)
>1.8* 38.46 (27.7–50.2) 86.67 (81.3–91.0) 24.3 (12.8–39.2) 92.7 (88.7–95.6) 2.88 (1.8–4.5) 0.71 (0.6–0.9)
Severe VUR >0.9 48.15 (34.3–62.2) 70.83 (48.9–87.4) 15.5 (4.2–35.9) 92.5 (81.9–97.9) 1.65 (0.8–3.3) 0.73 (0.5–1.1)
>1.8* 44.4 (30.9–58.6) 85.47 (80.3–89.7) 25.4 (14.2–39.6) 93.3 (89.3–96.1) 3.06 (2.0–4.7) 0.65 (0.5–0.8)
>2.3 40.74 (27.6–55.0) 83.33 (62.6–95.3) 21.4 (4.9–49.7) 92.7 (83.3–97.7) 2.44 (0.9–6.3) 0.71 (0.5–0.9)
>3.0 31.48 (19.5–45.6) 91.67 (73.0–99.0) 29.6 (5.1–68.4) 92.3 (83.4–97.3) 3.78 (0.9–15.1) 0.75 (0.6–0.9)
Table 5.  Diagnostic accuracy of DNI for the prediction of renal USG and DMSA abnormalities and VUR 
or severe VUR. DNI: delta neutrophil index, USG: ultrasonography, DMSA: dimercaptosuccinic acid, VUR: 
vesicoureteral reflux, LR: likelihood ratio, *Recommended cut-off value by Youden index.
WBC (/mm3) ESR (mm/hr) CRP (mg/L) DNI (%)
WBC (/mm3) — <0.01* (0.345)** <0.01 (0.449) 0.14 (0.087)
ESR (mm/hr) <0.01 (0.345) — <0.01 (0.494) 0.50 (−0.040)
CRP (mg/L) <0.01 (0.449) <0.01 (0.494) — 0.09 (0.099)
DNI (%) 0.14 (0.087) 0.50 (−0.040) 0.09 (0.099) —
Table 6.  Correlations between WBC, ESR, C-reactive protein and DNI in patients with UTI. UTI: Urinary 
tract infection, WBC: white blood cell, ESR: erythrocyte sedimentation rate, CRP: C-reactive protein, DNI: 
delta neutrophil index, *P-value, **Correlation coefficient.
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to the AUC of other markers especially the WBC count and ESR, the DNI holds much better accuracy almost 
equivalent to that of the CRP. Also, the DNI is the only marker with a statistically significant AUC (P value < 0.05) 
greater than 0.6 for all other categories including patients with DMSA abnormalities, VUR and severe VUR. 
Furthermore, in the case of patients with VUR and severe VUR, the DNI showed the highest and acceptable AUC 
value, thereby showing that it is the only marker with noteworthy accuracy as a diagnostic tool.
Our study also indicates that the DNI while having less than 50% sensitivities in all criterion values in all 
four categories, still has a moderate to high specificity ranging from 70 to 90%. Interestingly, such low sensitivity 
of DNI in UTI differs from the reports of high sensitivities ranging from 82% to 95% by previous studies27,29. 
However, this difference is most likely attributed to the fact that these past studies evaluated the DNI’s accuracy in 
patients with bacteremia and sepsis, both of which are considered as systemic infection unlike APN and the lower 
UTI, which is a localized infection that was analyzed in our study. In fact, in a study31 that analyzed the mean DNI 
in patients with bacteremia, sepsis and septic shock, the mean DNI for the above three conditions were 8.7%, 
24.2% and 35.6%, all of which are much higher than the 1.3% and 1.5% observed in APN patients with abnormal 
USG and DMSA in our study.
In regards to specificity, as expected, with an increase in the criterion or cut off values, the DNI specificities 
also increased due to reduced false positives. However, even at the lowest criterion, the DNI specificities range 
from 71% to 76%, which is consistent with the specificity of 75% reported by Lee et al.29. However, previous 
studies27,28,30 have also reported higher DNI specificities ranging from 84 to 95%. Similar to the sensitivities, the 
discrepancy between the specificity of DNI of our result with those of past studies is thought to have occurred 
due to the localization of the infection in the case of UTI. However, even with a specificity of ~70% in the case of 
APN, it is important to note that the positive likelihood ratio (LR) ranges from 1.33 to 3.78 and thus considering 
a pretest probability of 36.1%, which is the prevalence of VUR and severe VUR in our study, a posttest probability 
of at least 48.0% can be expected with this probability being greater with higher DNI value. Overall, however, such 
moderate specificity in presence of low sensitivity indicates that the DNI may be more suitable as a diagnostic 
predictive factor rather than a preliminary marker for screening in the case of APN.
Lastly, results of the correlation analysis indicates that while the WBC, ESR and CRP correlate well with each 
other, the DNI does not correlate with the rest of the inflammatory markers. This is expected considering the fact 
that the proliferation and introduction of immature neutrophils into the circulation occurs during the earliest 
phase of stress or infection before the total WBC count, ESR and CRP increases. The release and synthesis of pro-
calcitonin by thyroid C cells and various neuroendocrine tissues and CRP by the liver, although they have been 
reported to strongly correlate with the severity and mortality of infection such as sepsis, are presumed to play less 
important roles in an acute inflammation32,33. In such respect, DNI can be considered to be a better marker in 
identifying the early phase of an infection, making translation to faster intervention possible.
To summarize, this study is the first exploring the potential of using DNI as an adjunct diagnostic marker to 
distinguish APN from lower UTI. Furthermore, the results of our study indicate that the DNI may better serve 
in predicting VUR in young children compared to the other currently available conventional markers. However, 
due to the limitation of small study population and retrospective design of our study, further studies may still be 
needed to evaluate the relationship between the DNI and proinflammatory cytokines.
Methods
Patients and inclusion criteria. We retrospectively studied 288 infants less than 12 months old or young 
children who were hospitalized with a first febrile UTI in a 5-year period in Yonsei University Severance hospital 
from January 2010 to December 2014. The diagnosis of a febrile UTI was based on the following criteria: (1) fever 
of more than 38 °C, (2) pyuria (≥5 WBC counts per high-power field), (3) growth of a single organism (≥100,000 
colony-forming units/mL) in urine collected from sterile bag or transurethral catheterized specimen, (4) no pre-
vious history of UTI and no other coincidental infections and (5) imaging studies, including renal USG, DMSA, 
and voiding cystourethrogram (VCUG) were performed.
These patients are overlapped in our previous cohort2. Empirical antibiotics with intravenous ceftriaxone or 
cefotaxime were initiated in all patients for 3–7 days, which were changed to oral antibiotics after 7 days. Total 
duration of treatment was 14 days. Patients were divided into the two groups according to the presence of abnor-
malities on renal USG and DMSA scans or the presence of VUR or severe VUR.
Laboratory examinations and DNI. Before initiating antibiotic treatment, blood was sampled for labora-
tory investigations, including WBC count, ESR, and CRP at the time of visiting hospital. Peripheral venous blood 
samples were collected by antecubital venepuncture into Vacutainer tubes (Becton Dickinson™, Rutherford, NJ) 
containing tripotassium ethylenediaminetetraacetic acid (EDTA) and were immediately transported to the 
chemical laboratory department. CBC studies were done within one hour of blood sampling and we followed 
a standardized protocol. DNI is included as a part of the routine CBC tests at our institution. DNI calcula-
tion was carried out using an automatic cell analyzer (ADVIA 2120 Hematology System, Siemens Healthcare 
Diagnostics, Forchheim, Germany)5. After lysis of red blood cells, cell size and stain intensity were measured by 
the tungsten-halogen-based optical system of the MPO channel to count and differentiate granulocytes, lympho-
cytes, and monocytes based on their size and MPO content. Next, cells were counted and classified according 
to the size, lobularity, and nuclear density, using the laser diode-based optical system of the lobularity nuclear 
density channel. The DNI value was calculated using the following formula: DNI = [the neutrophil subfraction 
and the eosinophil subfraction measured in the MPO channel by the cytochemical MPO reaction]—[the poly-
morphonuclear neutrophil (PMN) subfraction measured in the nuclear lobularity channel by the reflected light 
beam]. The unit of DNI value was expressed as percentage (%). CRP levels were measured by the latex-enhanced 
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turbidimetric assay method using a Hitachi 7600 P module (Hitachi, Japan). ESR levels were measured by the 
TEST 1 (Alifax, Padova, Italy). Strict quality control procedures were adopted.
Imaging Studies. Renal USG was performed in all patients to detect anomalies in kidney and urinary tracts. 
DMSA scans were also performed within the first 5 days after admission to detect any renal parenchymal involve-
ment which was considered to be positive when a focal, multifocal, or diffuse decrease or absence of DMSA 
uptake was noted. Presence of renal parenchymal involvement on DMSA scan was determined by one nuclear 
medicine radiologist who was blinded to this study. VCUG was performed 1–2 weeks after the completion of 
UTI antibiotic treatment and VUR was diagnosed according to the International Reflux Study defined as the 
retrograde passage of urine from the bladder into ureters or kidney. Mild VUR was defined as VUR grade 1, 2 
and severe VUR as VUR grade 3–5. Parents were informed of the potential benefits and risks of DMSA scan and 
VCUG and their consents were received before the examinations.
Statistical methods. Statistical analyses were performed, using the SPSS for Windows version 18.0 (SPSS 
Inc., Chicago, Illinois, USA) and MedCalc version 15.8 (MedCalc Software, Belgium). The independent t-test 
was used for continuous variables and expressed as mean ± standard deviation (SD). Chi-square test was used 
to analyze categorical variables. Correlation analysis was also carried out to determine the relationship between 
two variables by Pearson correlation. Multiple logistic regression analysis was used to find independent predictive 
factors for renal USG and DMSA scan abnormalities or the presence of VUR and severe VUR. To establish the 
predictive value of the parameters for renal USG and DMSA scan abnormalities or the presence of VUR, receiver 
operating characteristic (ROC) curves were plotted for WBC, ESR, CRP and DNI. The diagnostic values of each 
cutoff point, including sensitivity, specificity, PPV, NPV and the likelihood ratio for a positive result, were all 
calculated. All differences were considered statistically significant at a P value < 0.05.
Ethics statement. The Institutional Review Board and Research Ethics Committee of Yonsei University 
Severance Hospital approved this study. We were given exemption from getting informed consents by the IRB 
because the present study was a retrospective study, personal identifiers were completely removed, and the data 
were analyzed anonymously. Our study was conducted according to the ethical standards laid down in the 1964 
Declaration of Helsinki and its later amendments.
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